LABCORP HOLDINGS INC.

Provides diagnostic lab testing and biopharma drug development services for healthcare clients.

LH | NYSE

Overview

Corporate Details

ISIN(s):: US5049221055
LEI:
Country:: United States of America
Address:: 358 S MAIN ST, 27215 BURLINGTON
Website:: https://www.labcorp.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Labcorp Holdings Inc. is a global life sciences company providing vital information to help doctors, hospitals, pharmaceutical companies, and patients make critical health decisions. The company operates through two primary segments: Diagnostics Laboratories and Biopharma Laboratory Services. The Diagnostics division offers a comprehensive menu of clinical laboratory tests, including specialty testing in areas like genetics and oncology, through an extensive network of patient service centers and direct-to-consumer platforms. The Biopharma segment provides end-to-end drug development solutions, including central laboratory services for clinical trials, nonclinical research, and real-world data analytics. By integrating its vast diagnostic data with its drug development expertise, Labcorp aims to accelerate medical innovation and improve health outcomes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all LABCORP HOLDINGS INC. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for LABCORP HOLDINGS INC.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for LABCORP HOLDINGS INC. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Public Policy Holding Company, Inc. Advisory group providing public policy, government relations, and strategic communications services.	United States of America	PPHC.L
Purple Biotech Ltd. Developing cancer therapies to overcome tumor immune evasion and drug resistance.	Israel	PPBT
Qualigen Therapeutics, Inc. A clinical-stage company developing innovative treatments for rare cancers in adults and children.	United States of America	QLGN
QUIA PHARMA AB Develops biobetters by enhancing approved drugs with a patented drug delivery platform.	Sweden	QUIA
QUINSTREET, INC AI-driven marketplaces connecting consumers to brands in finance & home services on a pay-per-result basis.	United States of America	QNST
Qurient Co., Ltd. Biopharma developing novel drugs for cancer, inflammation, and infectious diseases.	South Korea	115180
Rafael Holdings, Inc. Invests in and develops novel therapeutics for cancer and rare diseases.	United States of America	RFL
RaQualia Pharma Inc. An R&D firm discovering novel small molecules for out-licensing to pharma partners.	Japan	4579
Recruit Holdings Co., Ltd. Global provider of HR tech (Indeed), staffing services, and business SaaS solutions.	Japan	6098
RELMADA THERAPEUTICS, INC. A clinical-stage biotech developing novel therapies for CNS diseases and oncology.	United States of America	RLMD